Clinical Trial Update: Adjunctive Curcumin for Symptomatic Adolescents With Bipolar Disorder: Brain and Body Considerations [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating adjunctive curcumin for symptomatic adolescents with bipolar disorder has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Curcumin (curcumin)

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Bipolar Disorder | Phase 2 | Status: TERMINATED